Brainstorm Cell Therapeutics(DE:GHD)
€2.690.00 (0.00%)
DE:GHD
Brainstorm Cell Therapeutics stock forecast
€2.69
At close:0.00 (0.00%)
Brainstorm Cell Therapeutics (GHD) Stock Forecast & Price Target
1 Followers
GHD Analyst Ratings
Hold
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Brainstorm Cell Therapeutics in the past 3 months
GHD Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | ― | hold | ― | Reiterated | 08/18/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jason McCarthyMaxim Group | HoldReiterated | 08/18/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
GHD Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, GHD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GHD average Analyst price target in the past 3 months is ―.
GHD Financial Forecast
HighEUR -0.16
ConsensusEUR -0.16
LowEUR -0.16
GHD Earnings Forecast
Next quarter’s earnings estimate for GHD is -EUR 0.16 with a range of -EUR 0.16 to -EUR 0.16. The previous quarter’s EPS was -EUR 0.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusEUR 0.00
GHD Sales Forecast
Next quarter’s sales forecast for GHD is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
GHD Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
Brainstorm Cell Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Brainstorm Cell Therapeutics?
To buy shares of DE:GHD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
